Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2026-03-05 @ 4:55 PM
Study NCT ID:
NCT00548418
Status:
COMPLETED
Last Update Posted:
2014-08-01
First Post:
2007-10-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
Sponsor:
Washington University School of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
06-1098 / 201110266
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None